Looking to get your lipoma’s removed for free?
A double-blind study to evaluate the efficacy of collagenase histolyticum (XIAFLEX) in the treatment of lipoma is currently undergoing recruitment in the Long Island New York and Nashville Tennessee areas. If you live in or around these areas it might be a good idea to look at the trial and see if you qualify.
The goal of this trial is to see whether collagenase histolyticum is an effective agent in reducing the surface area of subcutaneous benign lipomas. The primary outcome measure is to reduce the size of the visible surface area of the lipoma within 6 months of the collagenase injection. You will also be given a questionnaire to assess satisfaction with treatment for both collagenase and placebo injections into the lipoma.
The study is designed to satisfy FDA requirements for safety and efficacy of approved drug (XIAFLEX) in the treatment of lipoma (fatty tumors). Lipomas are made up of normal fatty tissue (adipose tissue) but unlike normal fat they are encapsulated with a “balloon-like” structure composed of collagen (fibrous tissue – Watch this video). XIAFLEX, which is a protein that breaks down collagen is thought to dissolve the balloon-like structure and in turn decreasing the size of the lipoma or removing it completely.
To qualify, you need to have at least two lipomas; one for the placebo and one for the drug. Both will be observed for changes throughout the trial. You need to also be between the ages of 18 and 75, healthy, can be any race, and either sex. Probably the hardest criteria to satisfy is that your lipomas need to be at least 5cm squared (I do not think this equals the diameter, it means surface area), and each lipoma needs to be on distinctly different parts of the body (or on torso if 30cm apart).
There is also an extensive list of exclusion criteria which you should check out to see if you quality. You can find the trial details here. If you do end up participating, please let us know and come back and comment below!
Company behind the Trial: BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date: http://www.biospecifics.com/